Callodine Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $6.67M | Sell |
|
|||||
|
2023
Q2 | $7.67M | Buy |
|
|||||
|
2023
Q1 | $5.89M | Buy |
|
|||||
|
2022
Q4 | $5.76M | Sell |
|
|||||
|
2022
Q3 | $11.7M | Buy |
|
|||||
|
2022
Q2 | $5.58M | Sell |
|
|||||
|
2022
Q1 | $18.6M | Sell |
|
|||||
|
2021
Q4 | $16.8M | Sell |
|
|||||
|
2021
Q3 | $17.8M | Buy |
|
|||||
|
2021
Q2 | $18.5M | Buy |
|
|||||
|
2021
Q1 | $16.6M | Buy |
|
|||||
|
2020
Q4 | $12.4M | Buy |
|
|||||
|
2020
Q3 | $10.2M | Sell |
|
|||||
|
2020
Q2 | $11.2M | Sell |
|
|||||
|
2020
Q1 | $22M | Buy |
|
|||||
|
2019
Q4 | $19.9M | Buy |
|
|||||
|
2019
Q3 | $13.7M | Buy |
|
|||||
|
2019
Q2 | $2.72M | Buy |
|